Phibro Animal Health PAHC
NASDAQ PAHC
$35.02 -0.95 (-2.64%)
At close: Nov 16, 2026 · 4:00 PM EST

Phibro Animal Health (PAHC) Amortization of Deferred Charges (2012 - 2026)

Updated

Phibro Animal Health's Amortization of Deferred Charges was $617,000 in fiscal Q1 2027 (quarter ended Sep 30, 2026), up 7.9% from $572,000 a year earlier and up 2.7% from the prior quarter.

Analysis

Phibro Animal Health (PAHC) Amortization of Deferred Charges (2012 - 2026) Analysis & Trends

On a trailing twelve-month basis, Phibro Animal Health's Amortization of Deferred Charges was $2.36 million through Sep 30, 2026, up 6.4% year-over-year; for FY2026 (ended Jun 30, 2026), it came in at $2.32 million, up 15.0% from FY2025.

  • Amortization of Deferred Charges has now increased for four consecutive fiscal years, with a five-year compound annual growth rate of 22.7% (FY2021 to FY2026).
  • In earlier fiscal years, Amortization of Deferred Charges was $2.02 million in FY2025 (+93.8%), $1.04 million in FY2024 (+43.1%), $727,000 in FY2023 (+23.2%) and $590,000 in FY2022 (-29.2%).
  • The fiscal Q1 2027 figure marks the highest quarterly Amortization of Deferred Charges since fiscal Q4 2013.
  • Compared with a year earlier, Amortization of Deferred Charges was higher in seven of the last eight quarters, with growth averaging 52.0%.
  • The best year-over-year quarter for Amortization of Deferred Charges over five years was fiscal Q4 2025 (growth of 120.0%); the worst was fiscal Q3 2022 (a decline of 33.5%).
  • Per Business Quant data, PAHC's Amortization of Deferred Charges in the three fiscal quarters before Q1 2027 was $601,000 (Q4 2026), $572,000 (Q3 2026) and $572,000 (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn
10 Phibro Animal Health 1.42 Bn 1.11 Bn 128.54 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 617,000.00
Jun 30, 2026 601,000.00
Mar 31, 2026 572,000.00
Dec 31, 2025 572,000.00
Sep 30, 2025 572,000.00
Jun 30, 2025 572,000.00
Mar 31, 2025 572,000.00
Dec 31, 2024 504,000.00
Sep 30, 2024 367,000.00
Jun 30, 2024 260,000.00
Mar 31, 2024 260,000.00
Dec 31, 2023 260,000.00
Sep 30, 2023 260,000.00
Jun 30, 2023 213,000.00
Mar 31, 2023 188,000.00
Dec 31, 2022 179,000.00
Sep 30, 2022 147,000.00
Jun 30, 2022 148,000.00
Mar 31, 2022 147,000.00
Dec 31, 2021 147,000.00
API Access

Phibro Animal Health Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=PAHC&period=max&api_key=YOUR_API_KEY